UK has new standards for hospital infections:
This article was originally published in Clinica
UK Health Minister John Denham has announced new standards for National Health Service (NHS) hospitals on the management of hospital-acquired infection, such as meticillin-resistant Staphylococcus aureus. Specific standards will cover medical equipment and devices, management of medicines, professional and product liability and emergency preparedness. NHS trusts will have good practice standards assessed by March 2000. They will then be given four months to produce plans to implement the standards.
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.
Less-invasive technologies to treat benign prostatic hyperplasia are fast becoming viable alternatives to medication and surgery. Here's what one researcher in the area, Steven Raman, had to say about the new options.